What is the purpose of investigational product reconciliation at the end of a clinical trial?
-
A
To confirm that IP costs were within the contracted study budget
-
B
To verify that all IP received, dispensed, and returned or destroyed is fully accounted for
-
C
To determine the residual commercial value of remaining IP
-
D
To prepare unused IP for future commercial marketing